MacroGenics
MGNX
#8650
Rank
NZ$0.40 B
Marketcap
NZ$6.38
Share price
-7.73%
Change (1 day)
129.81%
Change (1 year)

MacroGenics (MGNX) - Total assets

Total assets on the balance sheet as of March 2026 : NZ$0.37 Billion

According to MacroGenics's latest financial reports the company's total assets are NZ$0.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

MacroGenics - Total assets on balance sheet (from 2012 to 2026)

Total assets by year

Year Total assets Change
2025-12-31NZ$0.44 B-4.41%
2024-12-31NZ$0.46 B-1.68%
2023-12-31NZ$0.47 B6.82%
2022-12-31NZ$0.44 B-10%
2021-12-31NZ$0.49 B-6.5%
2020-12-31NZ$0.52 B13.12%
2019-12-31NZ$0.46 B-6.29%
2018-12-31NZ$0.49 B-5.95%
2017-12-31NZ$0.52 B17.16%
2016-12-31NZ$0.44 B-14.4%
2015-12-31NZ$0.52 B136.53%
2014-12-31NZ$0.22 B44.99%
2013-12-31NZ$0.15 B134.28%
2012-12-31NZ$65.33 M-18.65%
2011-12-31NZ$80.31 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
NZ$357.76 B 95,193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$200.88 B 53,406.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$159.40 B 42,357.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$96.97 B 25,730.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$221.74 B 58,964.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$149.01 B 39,591.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
NZ$1.26 B 238.20%๐Ÿ‡บ๐Ÿ‡ธ USA